David L. Hill
Corporate Officer/Principal chez American Association of Bioanalysts
Profil
David L.
Hill is the founder of California Central Coast Ivf Laboratory founded in 2018.
He is currently an Assistant Professor at David Geffen School of Medicine and a Member of American Association of Bioanalysts.
He was an Independent Director at Stellar Biotechnologies, Inc. and served as the Scientific Director at Art Reproductive Center from 1999 to 2016.
Dr. Hill has an undergraduate and graduate degree from California Polytechnic State University and a doctorate from The University of Connecticut School of Medicine, which he received in 1983.
Postes actifs de David L. Hill
| Sociétés | Poste | Début |
|---|---|---|
| American Association of Bioanalysts | Corporate Officer/Principal | - |
| David Geffen School of Medicine | Corporate Officer/Principal | - |
Anciens postes connus de David L. Hill
| Sociétés | Poste | Fin |
|---|---|---|
| Art Reproductive Center | Directeur Technique/Scientifique/R&D | 01/12/2016 |
| California Central Coast Ivf Laboratory | Corporate Officer/Principal | - |
Stellar Biotechnologies, Inc.
 Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Directeur/Membre du Conseil | - |
Formation de David L. Hill
| California Polytechnic State University (San Luis Obispo) | Graduate Degree |
| The University of Connecticut School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Health Technology |
| Art Reproductive Center | |
| American Association of Bioanalysts | |
| California Central Coast Ivf Laboratory |